Loading...

Daily news and top headlines for life science research professionals

FREE Email Newsletter View Sample


Mass resignations at embattled state cancer agency

By PAUL J. WEBER - Associated Press - Associated Press Friday, October 12, 2024

See today's top life science stories and headlines - Sign up now!

newsvine diigo google
slashdot
Share
Loading...

At least seven scientists resigned in protest this week from Texas' embattled $3 billion cancer-fighting program, claiming the agency created with the backing of the governor and cancer survivor Lance Armstrong is charting a new "politically driven" path that puts commercial interests before science.

The Cancer Prevention and Research Institute of Texas has awarded nearly $700 million in grants since 2009, making Texas home to the nation's biggest pot of cancer-research dollars behind only the federal National Institutes of Health. But how it picks projects has fallen under intensifying scrutiny, beginning in May when its chief scientific officer resigned in protest after it approved — without scientific review — a $20 million commercialization project.

Nobel laureate Dr. Phillip Sharp was among those stepping down this week, writing in his resignation letter that the CPRI is making funding decisions that carry a "suspicion of favoritism" in how the state is handing out taxpayer dollars. Dr. Bryan Dynlacht, another reviewer who's leaving, warned that the agency was headed down a path of systematic abuses.

"You may find that it was not worth subverting the entire scientific enterprise — and my understanding was that the intended goal of CPRIT was to fund the best cancer research in Texas — on account of this ostensibly new, politically driven, commercialization-based mission," Dynlacht wrote in his letter.

Commercialization projects focus on turning research into drugs or other sellable products rather than funding the research itself.

The letters were obtained by The Associated Press through an open records request. Sharp is professor at the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology, while Dynlacht is at the New York University School of Medicine, wrote in his resignation letter.

In a statement, CPRIT executive director Bill Gimson called the accusations false and misinformed.

CPRIT was created though an ambitious bond measure approved by Texas voters in 2007. The agency has scientists across the country who help review proposals and choose projects to fund.

But in May, chief scientific officer Dr. Alfred Gilman resigned in protest after the CPRIT approved a $20 million grant for a so-called incubator project at M.D. Anderson Cancer Center in Houston. He told colleagues in heated emails that he was trying to prevent misuse of taxpayer dollars and funding decisions based on political considerations.

It was the largest amount of money the agency ever awarded for a single project. But since it was a commercialization project, it didn't undergo scientific review. The agency has since said the project would undergo such a review.

The latest resignations come on the eve of potentially significant changes in how the agency allocates funding. CPRIT has been steering 75 percent of all funding toward research, 15 percent toward commercialization, and 10 percent toward prevention efforts such as breast cancer screenings.

But those funding formulas could change at the agency's annual conference this month. Gimson has signaled that the time has come to put more money into private commercialization projects, saying that would get new drugs into the hands of patients quicker.

Dr. William Kaelin of Harvard Medical School, who served on CPRIT's scientific review council before he stepped down this week, said in his resignation letter that he recently learned two fellow reviewers who rejected the science behind two proposed commercialization projects were asked by state officials to reconsider their low marks. The letter neither cited the reviewers nor the officials.

"In this environment, I am not confident that scientific quality and rigor will triumph over grandiose promised and hucksterism," Kaelin wrote.

Gimson said the final decision on whether to revise scores still rests with each reviewer.

In his statement, Gimson said he wasn't surprised by the latest resignations given Gilman's departure, though he didn't elaborate. A successor has not yet been named.

___

Follow Paul J. Weber on Twitter: www.twitter.com/pauljweber

Join the Discussion
Rate Article: Average 4.5 out of 5
register or log in to comment on this article!

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

Research Exchange

Live Cell Analysis of Autophagy

Sep 4

Analysis of autophagosome formation using fluorescent cellular imaging and lentiviral biosensors.

Deconstructing 3D Cell Culture

Aug 31

3D culture models offer the potential to significantly reduce drug failure.

Safety Without Sacrifice

Safety Without Sacrifice

Jun 26

Liquid handling ergonomics and performance considerations

ELNs: The Beating Heart of a Scientist’s World

ELNs: The Beating Heart of a Scientist’s World

May 22

As ELNs deliver more benefits to researchers, the cost of changing working practice is outweighed by access to high quality, high context collaboration.

Evaluation of a New Nano-Type UV-Vis Spectrophotometer

Mar 3 2011

Analysis of one- to four-microliter size samples for nucleic acids has become routine in many life science laboratories. However, until now, available instruments require considerable manipulation of the instrument and sample; some require manually recording the data. The user must typically lower and raise the arm manually, then wipe the sample manually from the target after each analysis. And fiberoptics used in some of these instruments are subject to deterioration.

Production of Recombinant Proteins and Monoclonal Antibodies in Hollow Fiber Bioreactors

Jan 25 2011

While well-understood, robust and convenient, classical batch-style 2-D culture on non-porous supports or 3-D suspension culture in other devices are really not very biologically relevant models. Cell culture conditions can affect the quality of the antibody or protein produced.

Selecting Robots for Use in Drug Discovery and Testing

Dec 6 2010

Drug discovery and testing, with their need for speed, repeatability and verification, are ideally suited to benefit from robot automation. It is therefore not surprising that robots have been at the forefront of automation developments in both these areas.

HP Scalable Network Storage Systems for Life Sciences

Sep 13 2010

Life sciences research today is advancing exponentially, each step bringing us closer to the realization of truly personalized medicine–preventive care and treatments designed specifically for each individual. In the near future, PCPGM healthcare researchers expect to be able to use predictive genetic testing to create custom treatment plans for individuals and deliver dramatic improvements over today’s one-size-fits-all approach. But research capabilities are only part of the equation; current storage and operating capacities must also evolve to accommodate ever-expanding amounts of data before the goal of personalized medicine can be realized.

Using the Tecan Genesis Workstation to Automate a Cytometric Bead Array (CBA) Immunoassay

Mar 11 2010

The poster describe the process involved in automating a Cytometric Bead Array (CBA) immunoassay developed to measure relative concentrations of serum antibodies against Tetanus (TT), Sperm Whale Myoglobin (SWM) and Keyhole Limpet Hemocyanin (KLH) in KLH-immunized volunteers.

Ensuring Quality in Assays Performed with Automated Liquid Handlers

Feb 2 2010

The focus of this presentation is to highlight the need of ensuring quality in important assays performed with automated liquid handlers. Nearly all assays performed within a laboratory are volume-dependent. In turn, all concentrations of biological and chemical components in these assays, as well as the associated dilution protocols, are volume-dependent. Because analyte concentration is volume-dependent, an assay’s results might be falsely interpreted if liquid handler variability and inaccuracies are unknown or if the system(s) go unchecked for a long period.

Inkjet System for Protein Crystallography

Feb 1 2010

X-ray crystallography is used routinely by scientists to obtain the three dimensional structure of a biological molecule of interest.Such information can be used to determine how a pharmaceutical interacts with a protein target and what changes might improve functionality. However, the crystallization of macromolecules still remains a serious hindrance in structural determination despite impressive advances in screening methods and technologies.

Attention Deficit & Hyperactivity in a Drosophila Memory Mutant

Attention Deficit & Hyperactivity in a Drosophila Memory Mutant

Nov 9 2009

Action selection is modulated by external stimuli either directly or via memory retrieval. In a constantly changing environment, animals have evolved attention-like processes to effectively filter the incoming sensory stream. These attention-like processes, in turn, are modulated by memory. The neurobiological nature of how attention, action selection and memory are inter-connected is unknown. We describe here new phenotypes of the memory mutant radish in the fruit fly Drosophila.

Red Meat Consumption and Mortality: Results From 2 Prospective Cohort Studies

Mar 16

BACKGROUND: Red meat consumption has been associated with an increased risk of chronic diseases. However, its relationship with mortality remains uncertain. METHODS: We prospectively observed 37 698 men from the Health Professionals Follow-up Study (1986-2008)...

Structural analysis of eyespots: dynamics of morphogenic signals that govern elemental positions in butterfly wings.

Mar 15

ABSTRACT: BACKGROUND: To explain eyespot colour-pattern determination in butterfly wings, the induction model has been discussed based on colour-pattern analyses of various butterfly eyespots. However, a detailed structural analysis of eyespots that can serve as...

Prokariotic Cell Collection in Denmark

Nov 6 2009

I would like to know about a prokariotic cell collection in Denmark. Is there a cell bank in this country? I need a Lactobacillus strain for a fermentation assay and this information about the bank is very helpful for me.

Request for Entries

Oct 16 2009

Ask the Experts is your chance to get the answers to questions on applications, materials, methods, processes, and technologies. Email you question to bst_web@advantagemedia.com, and the editors of Bioscience Technology will find an appropriate expert to answer it. Watch this space in the future to see the questions your colleagues are posting.

STAY INFORMED: SUBSCRIBE TO

Magazine and E-mail Newsletters

Loading...
Loading...

Free Life Science Industry
Subscriptions

Magazine

wireless week

Newsletters

newsletters

Sign up now



MULTIMEDIA

Video:

Epigenetics

Aug 30

Hank & his clone Circus Hank explain the power of epigenetics, which studies the factors that determine how much or whether some genes are expressed in your body.

Podcasts:

Futures In Biotech 93: Snyder's Omics

May 17

Host: Marc Pelletier Co-Host: Andre Nantel, Ph.D. The technologies that our guest has developed are playing an important role in changing the world, not like the car, the microwave and the cell phone, but as in Drs. Flox, McCoy, and Crusher. Guest: Dr. Michael Snyder We invite...

Top Stories and Headlines
EVERY DAY!

FREE Email Newsletter

Information: